Health Insurance Amendment Act (Celiac Disease Screening), 2013 Mauro, Bill — Bill 75 (40th Parliament, 2nd Session)

Bill 75, 40-2

Ontario — Bills

role="main" class="main-container container js-quickedit-main-content" id="main-content">

Bill 75, Health Insurance Amendment Act (Celiac Disease Screening), 2013

Mauro, Bill

Please select

View bill

Status

Debates

Acts affected

Original

[40] Bill 75 Original (PDF)

Bill 75 2013

Act to amend the Health Insurance Act with respect to celiac disease screening

Note:

This Act amends the Health Insurance Act . For the legislative history

of the Act, see the Table of Consolidated Public Statutes – Detailed

Legislative History at www.e-Laws.gov.on.ca.

Preamble

Celiac

disease affects nearly one percent of Canada's population. It is a

condition in which a person's immune system reacts negatively to gluten in the

diet, causing damage to the person's small bowel and reducing their ability to

absorb nutrients. Over time, this can lead to vitamin deficiencies

that deprive the person's brain, peripheral nervous system, bones, liver and

various organs of vital nourishment.

Celiac

disease is associated with type 1 diabetes, down syndrome, thyroiditis,

arthritis, ataxia, depression, neuropathy, infertility and osteoporosis, as

well as other serious health conditions.

For

the initial detection of celiac disease, a simple and accurate serologic test

can be used, including the IgA-human tissue transglutaminase test and the

endomysial antibody test.

While

a small intestinal mucosal biopsy remains the "gold standard" for confirming

the diagnosis, the initial detection of celiac disease is extremely important.

Once

the disease is identified, in most cases, it can be effectively managed through

a gluten-free diet. Early diagnosis and treatment of the disease increases the

chances that damaged tissue will heal and reduces the possibility of long-term

complications.

Increasing

access to serological testing will improve the likelihood that Ontarians living

with celiac disease will be identified and treated.

Therefore,

Her Majesty,

by and with the advice and consent of the Legislative Assembly of the Province of Ontario, enacts as follows:

Section

11.2 of the Health Insurance Act is amended

by adding the following subsection:

Same,

celiac disease screening

(1.1) Screening for celiac disease through the use of the

IgA-human tissue transglutaminase test or the endomysial antibody test is an insured

service for the purposes of the Act.

Commencement

2. This

Act comes into force on the day it receives Royal Assent.

Short

title

3. The

short title of this Act is the Health Insurance Amendment

Act (Celiac Disease Screening), 2013 .

EXPLANATORY

NOTE

The

Bill amends the Health Insurance Act by making

screening for celiac disease through the use of specified tests an insured

service under the Act.

Date Bill stage Activity Committee

May 28, 2013

First Reading

Carried

Debates and Progress

First Reading

May 28, 2013

Committee

Second Reading

Committee

Third Reading

Acts affected - Bill 75

Most Ontario public acts are available electronically; to view copies of the Acts to be amended by this bill visit e-laws

Health Insurance Act

Legislative Assembly of Ontario

Was this page helpful? Yes , I found this page helpful. An optional survey will open in a new tab. No , I didn’t find this page helpful. An optional survey will open in a new tab.

Back to top

Document details

Collection	Ontario — Bills
Citation	Bill 75, 40-2
Type	bill
Volume / chapter	p40 s2 bill 75 html
Language	en
Format	html
Source	PROVINCIAL
Identifier	2916970a4d80b26d649f6731cedf89f432e3fafe

Source file is stored in the law ingest library (html).